Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Kampmann

Showing results (11-20 of 355) with videos related to

Pageof 36
Sort By:
Lancet (London, England)|August 2, 2021
COVID-19 vaccines for children in LMICs: another equity issueBeate Kampmann, Uduak Okomo
Innere Medizin (Heidelberg, Germany)|October 25, 2024
[Vaccination against respiratory syncytial virus (RSV)-For the protection of infants and older adults]Caitlin Pley, Beate Kampmann
Vaccine|June 29, 2024
Opportunities and challenges to the development and deployment of vaccines for pregnant women in GermanyCaitlin Pley, Beate Kampmann
BMJ (Clinical Research Ed.)|June 30, 2022
No one is safe until everyone is safe-from polio tooEd Clarke, Beate Kampmann
The Lancet. Infectious Diseases|February 22, 2024
Access to respiratory syncytial virus preventive tools for neonates and infants in EuropeCaitlin Pley, Beate Kampmann
Nature Medicine|October 9, 2025
Ebola vaccine safe for mothers and infantsBeate Kampmann, Alice Hucko
Seminars in Immunopathology|November 11, 2017
Vaccine responses in newbornsAnja Saso, Beate Kampmann
Thorax|December 19, 2015
What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?Martina Sester, Beate Kampmann
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 10, 2014
Preventive chemotherapy for contacts of MDR-TB: is the proof in the pudding?Christoph Lange, Beate Kampmann
Vaccine|April 17, 2014
Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?Kirsty Le Doare, Beate Kampmann
Pageof 36

Showing results (11-20 of 355) with videos related to

Sort By:
Pageof 36
Lancet (London, England)|August 2, 2021
COVID-19 vaccines for children in LMICs: another equity issueBeate Kampmann, Uduak Okomo
Innere Medizin (Heidelberg, Germany)|October 25, 2024
[Vaccination against respiratory syncytial virus (RSV)-For the protection of infants and older adults]Caitlin Pley, Beate Kampmann
Vaccine|June 29, 2024
Opportunities and challenges to the development and deployment of vaccines for pregnant women in GermanyCaitlin Pley, Beate Kampmann
BMJ (Clinical Research Ed.)|June 30, 2022
No one is safe until everyone is safe-from polio tooEd Clarke, Beate Kampmann
The Lancet. Infectious Diseases|February 22, 2024
Access to respiratory syncytial virus preventive tools for neonates and infants in EuropeCaitlin Pley, Beate Kampmann
Nature Medicine|October 9, 2025
Ebola vaccine safe for mothers and infantsBeate Kampmann, Alice Hucko
Seminars in Immunopathology|November 11, 2017
Vaccine responses in newbornsAnja Saso, Beate Kampmann
Thorax|December 19, 2015
What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases?Martina Sester, Beate Kampmann
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 10, 2014
Preventive chemotherapy for contacts of MDR-TB: is the proof in the pudding?Christoph Lange, Beate Kampmann
Vaccine|April 17, 2014
Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?Kirsty Le Doare, Beate Kampmann
Pageof 36